额部纤维性脱发:意大利单中心65例病例系列分析
该研究回顾性分析了2005至2017年意大利某皮肤科单位诊断的65例白人女性额部纤维性脱发(FFA)患者的流行病学、临床及毛发镜特征。结果显示21%为绝经前起病,86.1%伴眉毛脱落,约半数合并其他自身免疫病,75%患者治疗停止进展,但25%患者发际线仍继续后退。
要点
- FFA并非罕见绝经前起病,21%患者绝经前起病。
- 眉毛脱落可为FFA首发表现,86.1%患者出现眉毛脱发。
- 瘙痒、毛囊角化过度及毛发镜下红斑提示疾病进展。
核心结论
- 额部纤维性脱发并非罕见绝经前起病,眉毛脱落可为疾病首发表现。
- 约50%的FFA患者合并其他自身免疫病,疾病严重程度与病程无关。
- 瘙痒、毛囊角化过度及毛发镜下红斑是疾病进展的征象。
- 25%的患者尽管接受治疗,发际线后退仍继续进展。
研究设计与样本
- 回顾性病例系列,纳入2005至2017年意大利某皮肤科单位诊断的65例白人女性FFA患者。
- 将患者的临床、毛发镜、组织病理学及医疗资料与文献及一般人群数据进行比较。
主要发现
- 2005至2017年共诊断65例白人女性FFA,每年诊断例数逐渐上升。
- 21%的患者为绝经前起病,额部发际线后退伴颞部受累占80%、枕部受累占12.3%,眉毛脱发占86.1%,6例眉毛脱发先于头发脱落。
- 1/3患者出现非炎性面部丘疹,2/3患者报告瘙痒且瘙痒提示疾病进展。
- 毛发镜显示空毛囊/黄点、毛囊开口消失、轻度毛囊角化过度、毛囊周围红斑及「孤立毛」。
- 头皮扁平苔藓毛发受累见于15例,女性型脱发见于22例。
关键数值与推荐
- 治疗包括短期系统或皮损内注射糖皮质激素,随后使用5α-还原酶抑制剂、羟氯喹及外用药物。
- 75%的患者FFA进展停止,16例患者尽管接受治疗发际线仍恶化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Frontal fibrosing alopecia (FFA) is increasing in prevalence worldwide and several series from different countries have been published, in order to detect possible causes of the disease outbreak. OBJECTIVE: To analyze the epidemiological, clinical and trichoscopic features of FFA seen in an Italian Dermatology Unit. METHODS: Clinical, trichoscopy, histopathology and medical details of all patients were compared with literature and general population data. RESULTS: From 2005 to 2017, we diagnosed FFA in 65 Caucasian females, with the number of diagnoses per year progressively rising. Premenopausal onset was detected in 21%. Frontal hair line recession was associated with parietal involvement in 80% of cases, occipital in 12.3% and eyebrows alopecia in 86.1%. In six cases, eyebrow alopecia preceded hair loss. Non-inflammatory facial papules were detected in 1/3 of the patients. Itching was reported by 2/3 of the patients and was indicative of disease progression. Trichoscopy showed empty follicles/yellow dots, absence of follicular ostia, mild follicular hyperkeratosis, perifollicular erythema and 'lonely hair'. Scalp lichen plano-pilaris was seen in 15 patients, female pattern hair loss in 22. Therapy included short-term treatment with systemic or intralesional corticosteroids followed by therapy with 5α-reductase inhibitors of hydroxychloroquine and topical drugs. Arrest of FFA progression was seen in 75% of the patients, while 16 experienced worsening of the hairline despite therapy. CONCLUSIONS: Frontal fibrosing alopecia not rarely starts before menopause, loss of the eyebrows can be the first sign of the disease, about 50% of the patients have other autoimmune conditions, FFA severity is not related to its duration, itching, follicular hyperkeratosis and erythema at trichoscopy are signs of disease progression, 25% of the patients show progression of hairline recession despite therapy.
引用
- Starace M, Brandi N, Alessandrini A, et al. Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre. J Eur Acad Dermatol Venereol. 2018. PMID: 30472804. doi:10.1111/jdv.15372
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。